United States · FDA National Drug Code directory
Dobutamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70436-203_49562559-8e19-fb8a-e063-6394a90a0966
- Product NDC
- 70436-203
- Form
- INJECTION
- Composition / generic term
- dobutamine
- Labeler
- Slate Run Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230403
- Source listing expiry
- 20271231
Source-listed ingredients
- DOBUTAMINE HYDROCHLORIDE — 250 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-80) / 20 mL in 1 VIAL, SINGLE-DOSE · 70436-203-80
- 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-82) / 20 mL in 1 VIAL, SINGLE-DOSE · 70436-203-82
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →